Growth Metrics

Veracyte (VCYT) Shares Outstanding (Diluted Average) (2019 - 2025)

Historic Shares Outstanding (Diluted Average) for Veracyte (VCYT) over the last 7 years, with Q3 2025 value amounting to $79.9 million.

  • Veracyte's Shares Outstanding (Diluted Average) rose 188.8% to $79.9 million in Q3 2025 from the same period last year, while for Sep 2025 it was $79.9 million, marking a year-over-year increase of 188.8%. This contributed to the annual value of $78.2 million for FY2024, which is 759.69% up from last year.
  • Latest data reveals that Veracyte reported Shares Outstanding (Diluted Average) of $79.9 million as of Q3 2025, which was up 188.8% from $79.9 million recorded in Q2 2025.
  • In the past 5 years, Veracyte's Shares Outstanding (Diluted Average) registered a high of $80.1 million during Q1 2025, and its lowest value of $63.3 million during Q1 2021.
  • Over the past 5 years, Veracyte's median Shares Outstanding (Diluted Average) value was $72.5 million (recorded in 2023), while the average stood at $73.3 million.
  • In the last 5 years, Veracyte's Shares Outstanding (Diluted Average) skyrocketed by 3406.34% in 2021 and then skyrocketed by 132.78% in 2023.
  • Veracyte's Shares Outstanding (Diluted Average) (Quarter) stood at $67.9 million in 2021, then grew by 5.39% to $71.5 million in 2022, then rose by 1.53% to $72.6 million in 2023, then increased by 7.6% to $78.2 million in 2024, then grew by 2.28% to $79.9 million in 2025.
  • Its Shares Outstanding (Diluted Average) stands at $79.9 million for Q3 2025, versus $79.9 million for Q2 2025 and $80.1 million for Q1 2025.